• Continued research and development of our proprietary auto-immune and Alzheimer disease therapies
• Work closely with top research scientists in the field to reduce time, costs and to access government grants for product research and development
• Out-licensing technology and intellectual property assets
The company has attracted an outstanding team of
scientists, and clinical experts who have been at
the forefront of research and development in
auto-immune disease, Multiple Screlosis, Rheumatoid
Arthritis, Alzheimer Disease, and Duchene Muscular
Dystropy. With the depth of experience and expertise
in inhalation delivery, InnoBioscience is uniquely
positioned to develop a portfolio of its own
products to treat patients with these unmet medical
needs.